Protein synthesis dependent effects of kinins on astrocyte prostaglandin synthesis

Peptides

Volumn 31, Issue 4, 2010, Pages 651-656

  Filipovich Rimon, Talia ^a   Fleisher Berkovich, Sigal ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Astrocytes; B1 receptor agonist; Bradykinin; Lipopolysaccharide; Prostaglandins

Indexed keywords

BRADYKININ; BRADYKININ B1 RECEPTOR; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; KALLIDIN[1-9]; LIPOPOLYSACCHARIDE; PROSTAGLANDIN E2;

ANIMAL CELL; ARTICLE; ASTROCYTE; CONTROLLED STUDY; ENZYME SYNTHESIS; FEEDBACK SYSTEM; INFLAMMATION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT;

ANIMALS; ASTROCYTES; BRADYKININ; CYCLOHEXIMIDE; DACTINOMYCIN; DINOPROSTONE; LIPOPOLYSACCHARIDES; PROSTAGLANDINS; PROTEIN SYNTHESIS INHIBITORS; RATS; RATS, WISTAR; RECEPTOR, BRADYKININ B1;

RATTUS;

EID: 77649235466     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2009.12.006     Document Type: Article

References (34)

1. Akiyama H., Barger S., Barnum S., Bardt B., Bauer J., Cole G.M., et al. Inflammation and Alzheimer's disease. Neurobiol Aging 21 (2000) 383-421
2. 2 provides protection from cerebral infraction and brain edema. Stroke 40 (2009) 285-293
3. Bhoola K.D., Figueroa C.D., and Worthy K. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol Rev 44 (1992) 1-80
4. 2 receptors rescue motor neurons in a model of amyotrophic lateral sclerosis. Ann Neurol 56 (2004) 240-248
5. Blaukat A. Structure and signaling pathways of kinin receptors. Andrologia 35 (2003) 17-23
6. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72 (1976) 248-254
7. Couture R., Harrisson M., Vianna R.M., and Cloutier F. Kinin receptors in pain and inflammation. Eur J Pharmacol 429 (2001) 161-176
8. 2 kinin receptor. Eur J Pharmacol 573 (2007) 221-229
9. Dray A., and Perkins M. Bradykinin and inflammatory pain. Trends Neurosci 16 (1993) 99-104
10. Eng L.F., and Ghirnikar R.S. GFAP and astrogliosis. Brain Pathol 4 (1994) 229-237
11. Fiebich B.L., Schleicher S., Spleiss O., Czygan M., and Hull M. Mechanisms of prostaglandin E2-induced interleukin-6 release in astrocytes: possible involvement of EP4-like receptors, p38 mitogen-activated protein kinase and protein kinase C. J Neurochem 79 (2001) 950-958
12. 2 levels in patients with probable AD. Neurology 55 (2000) 323
13. Hsieh H.L., Wang H.H., Wu C.Y., Jou M.J., Yen M.H., Parker P., et al. BK-induced COX-2 expression via PKC-delta-dependent activation of p42/p44 MAPK and NF-kappaB in astrocytes. Cell Signal 19 (2007) 330-340
14. 2 by the activation of cyclooxygenase 2. Neurosci Lett 401 (2006) 242-247
15. Iores-Marcal L.M., Viel T.A., Buck H.S., Nunes V.A., and Gozzo A.J. Cruz-Silva bradykinin release and inactivation in brain of rats submitted to an experimental model of Alzheimer's disease. Peptides 27 (2006) 3363-3369
16. Kamiya T., Katayama Y., Kashiwagi F., and Terashi A. The role of bradykinin in mediating ischemic brain edema in rats. Stroke 24 (1993) 571-575
17. Levant A., Levy E., Argaman M., and Fleisher-Berkovich S. Kinins and neuroinflammation: dual effect on prostaglandin synthesis. Eur J Pharmacol 546 (2006) 197-200
18. Levy E., and Fleisher-Berkovich S. Regulation of glial cyclooxygenase by bradykinin. Peptides 28 (2007) 845-850
19. 2 EP2 receptor reduces oxidative damage and amyloid burden in a model of Alzheimer's disease. J Neurosci 25 (2005) 10180-10187
20. 1 receptors: a review. Immunopharmacology 30 (1995) 1-26
21. Nie M., Pang L., and Knox A.J. Transcriptional regulation of cyclooxygenase 2 by bradykinin and interleukin-1 beta in human airway smooth muscle cells: involvement of different promoter elements, transcription factors and histone h4 acetylation. Mol Cell Biol 23 (2003) 9233-9244
22. Nimmo A.J., and Vink R. Recent patents in CNS drug discovery: the management of inflammation in the central nervous system. Recent Pat CNS Drug Discov 4 (2009) 86-95
23. Noda M., Kariura Y., Pannasch U., Nishikawa K., Wang L., Seike T., et al. Neuroprotective role of bradykinin because of the attenuation of pro-inflammatory cytokine release from activated microglia. J Neurochem 101 (2007) 397-410
24. Noda ., Kariura M., Amano Y., Manago T., Nishikawa Y., Aoki K., et al. Kinin receptors in cultured rat microglia. Neurochem Int 45 (2004) 437-442
25. Noda M., Sasaki K., Ifuku M., and Wada K. Multifunctional effects of bradykinin on glial cells in relation to potential anti-inflammatory effects. Neurochem Int 51 (2007) 185-191
26. O'Banion M.K. Cyclooxygenase-2: molecular biology, pharmacology, and neurobiology. Crit Rev Neurobiol 13 (1999) 45-82
27. 2 release by bradykinin in human airway smooth muscle cells: involvement of cyclooxygenase 2 induction. Am J Physiol 273 (1997) L1132-L1140
28. Rodriguez J.A., De la Cerda P., Collyer E., Decap V., Vio C.P., and Velarde V. Cyclooxygenase-2 induction by bradykinin in aortic vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 290 (2006) H30-H36
29. 1 receptor in fresh or cultured rabbit aortic smooth muscle: role of NF-κB. Am J Physiol Heart Circ Physiol 283 (2002) H227-H237
30. Sobey C.G., Heistad D.D., and Faraci F.M. Mechanisms of bradykinin-induced cerebral vasodilatation in rats. Evidence that reactive oxygen species activate K+ channels. Stroke 28 (1997) 2290-2295
31. Wahl M., Whalley E.T., Unterberg A., Schilling L., Parsons A.A., Baethmann A., et al. Vasomotor and permeability effects of bradykinin in the cerebral microcirculation. Immunopharmacology 33 (1996) 257-263
32. Walker K., Perkins M., and Dray A. Kinins and kinin receptors in the nervous system. Neurochem Int 26 (1995) 1-26
33. Zhang W., Bhola N., Kalyankrishna S., Gooding W., Hunt J., Seethala R., et al. Kinin b2 receptor mediates induction of cyclooxygenase-2 and is overexpressed in head and neck squamous cell carcinomas. Mol Cancer Res 6 (2008) 1946-1956
34. 2 receptor antagonist, reduces intracranial hypertension and histopathological damage after experimental traumatic brain injury. Neurosci Lett 454 (2009) 115-117